Discussion
AC Immune has been awarded $4 million to extend the first part of an ongoing clinical trial that’s testing ACI-7104, its experimental vaccine targeting alpha-synuclein protein clumping, which is a hallmark of Parkinson’s disease. The grant, funded by the Vijay and Marie Goradia Charitable Foundation, will allow…
